Rilotumumab (Anti-HGF / SF)

Ask supplier a question | View on supplier's website

Rilotumumab (Anti-HGF / SF) is a monoclonal antibody that inhibits HGF/MET-driven signaling. Rilotumumab shows anti-tumor activity, and can be used in castration-resistant prostate cancer (CRPC) and solid tumor research. MW: 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2469
Sku #	A2469-1mg*5
Pricing	1mg*5, $970.00

Feedback